Hypertriglyceridemia in renal transplant recipients treated with sirolimus.
Brattström
C
C
Department of Transplantation Surgery, Huddinge Hospital, Stockholm, Sweden.
Wilczek
H E
HE
Tydén
G
G
Böttiger
Y
Y
Säwe
J
J
Groth
C G
CG
D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D020123:Sirolimus / Q000009:adverse effects* / Q000097:blood; D014280:Triglycerides / Q000097:blood
D007166:Immunosuppressive Agents; D014280:Triglycerides; D002784:Cholesterol; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine; D020123:Sirolimus